ABU-SHAAR, MUNA   DECHERT LLP
15
Betreute Anmeldungen
Technische BereichePatente
Biotechnologie10
Pharmazeutika5
Medizinische Technologie1

Heimatländer der Klienten

Zusammenfassung

ABU-SHAAR, Muna ist besonders erfahren in den Technologien „Biotechnologie“ und „Pharmazeutika“. 87% aller Patente wurden im Bereich „(Bio-)Chemie“ betreut. Die wichtigsten Klienten sind „ABBOTT BIOTHERAPEUTICS CORP.“ und „PROTEON THERAPEUTICS, INC.“. Besonders viele Patentanmeldungen wurden in den Jahren 2011 und 2010 betreut. Die Klienten stammen oftmals aus USA.

Patente nach Jahren

Patente nach Bereichen

1
Patentanmeldungen
13
Patentanmeldungen

Patente nach Anmeldern

RangNameLandPatente
1ABBOTT BIOTHERAPEUTICS CORP.USA5
2PROTEON THERAPEUTICS, INC.USA2
3UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCENiederlande2
4ABBVIE BIOTHERAPEUTICS INC.USA1
5CLEVELAND CLINICKanada1
6KELLBENX INCORPORATEDUSA1
7MESOTEX, INC.USA1
8SONOMACEUTICALS, LLCUSA1
9THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTUREUSA1
10UNIVERSITY OF KANSASUSA1

Letzte Anmeldungen

PublikationsnummerTitelPatentanmelderJahr
WO2016178931PROCESS FOR SEPARATING NUCLEATED CELLS FROM NON-NUCLEATED RED BLOOD CELLSMESOTEX, INC.
2016
WO2016022472MAMMALIAN PLURIPOTENT STEM CELLS, METHODS FOR THEIR PRODUCTION, AND USES THEREOFUNIVERSITY OF KANSAS
2016
WO2015175562PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCS) FOR DIAGNOSTIC TESTINGKELLBENX INCORPORATED
2015
WO2014144935ANTI-CD25 ANTIBODIES AND THEIR USES2014
WO2014047222METHODS FOR IDENTIFYING ANTIBODIES WITH REDUCED IMMUNOGENICITYABBVIE BIOTHERAPEUTICS INC.
2014
WO2013165921THERAPEUTIC USE OF CHARDONNAY SEED PRODUCTSSONOMACEUTICALS, LLC
THE GOVERNMENT OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE
2013
WO2011113019CTLA4 PROTEINS AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2011
WO2011059762ANTI-EGFR ANTIBODIES AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2011
WO2011053321USE OF AUTOLOGOUS EFFECTOR CELLS FOR TREATMENT OF MULTIPLE MYELOMAUNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCE
2011
WO2011053322USE OF AUTOLOGOUS EFFECTOR CELLS AND ANTIBODIES FOR TREATMENT OF MULTIPLE MYELOMAUNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCE
2011
WO2010148223ANTI-VEGF ANTIBODIES AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2010
WO2010121140ANTI-TNF-α ANTIBODIES AND THEIR USESABBOTT BIOTHERAPEUTICS CORP.
2010
WO2010051391USE OF ANTI-CS1 ANTIBODIES FOR TREATMENT OF RARE LYMPHOMASCLEVELAND CLINIC
ABBOTT BIOTHERAPEUTICS CORP.
2010
WO2009097621MEDICAL DEVICEPROTEON THERAPEUTICS, INC.
2009
WO2009079220RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOFPROTEON THERAPEUTICS, INC.
2009